|
2024
|
Invention
|
Platelet count-agnostic methods of treating myelofibrosis.
Reanalysis of the SIMPLIFY 1 and 2 tr... |
|
2023
|
Invention
|
Combination therapy comprising jaktinib. The present disclosure relates to combination therapies ... |
|
|
G/S
|
Antibiotic preparations |
|
|
Invention
|
Prolyl hydroxylase inhibitors.
The invention described herein relates to certain pyrimidinetrion... |
|
2022
|
Invention
|
Momelotinib combination therapy.
The present disclosure relates to methods of treating an inflam... |
|
|
Invention
|
Momelotinib combination therapy. The present disclosure relates to methods of treating an inflamm... |
|
|
Invention
|
Biomarker and patient selection in treatment for myelofibrosis. Transfusion independence in, and ... |
|
|
G/S
|
Pharmaceutical preparations and drugs for the treatment of cancer, namely, Myelofibrosis (MF); ph... |
|
|
Invention
|
Phenyl amino pyrimidine compounds and uses thereof.
The present invention relates to phenyl amin... |
|
2021
|
Invention
|
Prolyl hydroxylase inhibitors. The invention described herein relates to certain pyrimidinetrione... |
|
|
G/S
|
Pharmaceuticals preparations and drugs; pharmaceutical preparations and drugs for the treatment o... |
|
|
Invention
|
Methods of using momelotinib to treat joint inflammation.
The disclosure provides methods of tre... |
|
|
G/S
|
Pharmaceutical preparations and drugs; pharmaceutical
preparations and drugs for the treatment o... |
|
2020
|
Invention
|
N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide. The present invention rel... |
|
|
G/S
|
Pharmaceutical preparations and drugs for the treatment of cancer, namely, myelofibrosis (mf); ph... |
|
|
G/S
|
Pharmaceutical research and development; development of pharmaceutical preparations and drugs; de... |
|
|
Invention
|
Oil/surfactant mixtures for self-emulsification. Methods of manufacturing squalene and alpha-toco... |
|
2019
|
Invention
|
Methods for administering anti-il-5 antibodies.
The present invention relates generally to the m... |
|
|
Invention
|
Methods of treatment of eosinophilic bronchitis with an anti-il-5 antibody. The present invention... |
|
|
Invention
|
Methods of treatment of cancer comprising cdc7 inhibitors.
Herein disclosed are methods of treat... |
|
|
Invention
|
Methods of treatment of cancer comprising cdc7 inhibitors. Herein disclosed are methods of treatm... |
|
|
Invention
|
Platelet count-agnostic methods of treating myelofibrosis. 9/L. Also described are methods includ... |
|
|
Invention
|
Platelet count-agnostic methods of treating myelofibrosis. Reanalysis of the SIMPLIFY 1 and 2 tri... |
|
|
Invention
|
Benzimidazole derivatives as pi3 kinase inhibitors. This invention relates to the use of benzimid... |
|
|
Invention
|
Pharmaceutical compositions.
The present invention provides liquid compositions comprising albig... |
|
|
Invention
|
Compounds as diacylglycerol acyltransferase inhibitors. This invention relates to methods for the... |
|
2018
|
Invention
|
Container cap with a liner retention structure. A cap (100) for a container (300) having a pair o... |
|
|
Invention
|
6-amino-purin-8-one compounds.
Compounds of formula (I):
Compounds of formula (I):
Compo... |
|
|
Invention
|
Composition.
Compound (I), and pharmaceutically acceptable salts thereof, are inducers of human ... |
|
|
Invention
|
Methods for determining total body skeletal muscle mass.
The present invention is based on the f... |
|
|
Invention
|
Pyrazolopyrimidine compounds.
Compounds of formula (I) and salts thereof:
Compounds of formula... |
|
|
Invention
|
Biopharmaceutical compositions and methods for pediatric patients. The present disclosure relates... |
|
|
Invention
|
Enhancer of zeste homolog 2 inhibitors. This invention relates to novel substituted benzamide acc... |
|
|
Invention
|
Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators.
Provided herein are n... |
|
|
Invention
|
Novel compounds.
Compounds of formula (I) and salts thereof:
Compounds of formula (I) and salt... |
|
2017
|
Invention
|
6-amino-purin-8-one compounds. Compounds of formula (I):
3-7cycloalkyloxy; m is an integer havin... |
|
|
Invention
|
Pharmaceutical dosage form. A new oral solid dosage form of dutasteride, including fixed dose com... |
|
|
Invention
|
Methods of treatment of eosinophilic bronchitis with an anti-il-5 antibody.
The present inventio... |
|
|
Invention
|
Pharmaceutical compositions.
The present Invention relates to long acting pharmaceutical composi... |
|
|
Invention
|
Novel crystalline forms of an antiviral benzimidazole compound.
The invention relates to crystal... |
|
|
Invention
|
Combination drug therapy.
A novel combination comprising the 17 α-hydroxylase/C17,20 lyase inhib... |
|
|
Invention
|
Treatment of acvr1-mediated diseases. Provided herein are methods, compositions, and kits for tre... |
|
|
Invention
|
Substituted bridged urea analogs as sirtuin modulators.
Provided herein are novel substituted br... |
|
|
G/S
|
Biological and chemical preparations for the treatment of cancer; Pharmaceutical products, prepar... |
|
|
Invention
|
Methods of treating cancer.
This invention relates to methods of treating cancer in a subject in... |
|
|
G/S
|
Biological, chemical and pharmaceutical products, preparations and compounds for the treatment of... |
|
2016
|
Invention
|
Methods of use of a class iia hdac inhibitor.
Novel uses of selective class IIa HDAC inhibitors ... |
|
2015
|
Invention
|
Substituted bridged urea analogs as sirtuin modulators. The present invention relates to novel su... |
|
|
Invention
|
Pharmaceutical composition.
The present invention provides liquid compositions comprising albigl... |
|
2013
|
G/S
|
Pharmaceutical preparations for the treatment of gastrointestinal disorders |
|
|
G/S
|
Pillows |
|
2011
|
G/S
|
Pharmaceutical and medicinal preparations and substances;
vaccines. |
|
|
G/S
|
Pharmaceutical and medicinal preparations and substances; vaccines. |
|
2008
|
G/S
|
Pharmaceutical preparations for the treatment of cancer. |
|
|
G/S
|
Pharmaceutical and medicinal preparations for human use. |
|
|
G/S
|
Pharmaceutical and medicinal preparations for human use with the exclusion of pharmaceuticals for... |
|
2003
|
G/S
|
Pharmaceutical and medicinal preparations, namely anti-depressants. |
|
|
G/S
|
Pharmaceutical and medicinal preparations and substances for human use. |
|
2001
|
G/S
|
pharmaceuticals to treat and prevent urological and prostate related diseases and disorders |
|
|
G/S
|
pharmaceuticals to treat diseases and disorders of the central nervous system |
|
1999
|
G/S
|
Dosage form for pharmaceutical preparations. |
|
1998
|
G/S
|
Antibiotic preparations for veterinary use. |
|
1995
|
G/S
|
Advertising and promotional services relating to the sale of pharmaceutical products. |
|
|
G/S
|
human pharmaceuticals, namely anthelmintics |
|
1991
|
G/S
|
pharmaceuticals; namely, antidepressants |
|
|
G/S
|
Pharmaceutical preparations namely anti-depressants. |
|
1988
|
G/S
|
Anti-inflammatory pharmaceutical preparations. |
|
1985
|
G/S
|
PHARMACEUTICAL NAMELY, AMOXICILLIN TRIHYDRATE/CLAVULANATE POTASSIUM FOR VETERINARY USE |
|
1979
|
G/S
|
Antibiotic preparations. |
|
|
G/S
|
Tranquilizers. |
|
1972
|
G/S
|
Antibiotic preparation. |
|
|
G/S
|
ANTIBIOTIC PREPARATION |
|
1964
|
G/S
|
Oral preparation for use as a tobacco smoking deterrent. |
|
1962
|
G/S
|
Antibiotics and antibiotic preparations. |
